Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma's 'information arms dealer' is up nearly 80% from an April low. Josh Brown sees more gains
(This is The Best Stocks in the Market, brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — On Thursdays, we use this column to highlight a single name. Sometimes it's Nvidia, sometimes it's a stock you've…
Rigel Pharmaceuticals: Turning Big Pharma's Castoffs Into A Growth Engine (NASDAQ:RIGL)
Rigel Pharmaceuticals is evolving into a multi-product oncology platform, leveraging Big Pharma castoffs to drive growth beyond its ITP legacy. VEPPANU's U.S. launch targets a $1B ESR1-mutated breast cancer market, with early metrics excluded from…
3 Reasons Royalty Pharma Is a Dividend Stock You Never Have to Sell
Healthcare isn't optional, which makes the pharmaceutical sector fairly resilient through the entire economic cycle. Royalty Pharma (RPRX +1.75%) has created a diversified portfolio of royalties on drugs that are approved for sale and on drugs that…
LSL PHARMA GROUP INC. TO PRESENT AT THE 'PLANET MICROCAP TORONTO 2026'
BOUCHERVILLE, QC, Oct. 22, 2026 /CNW/ -- LSL PHARMA GROUP INC. (TSXV: LSL) (the 'Corporation' or 'LSL Pharma'), a Canadian integrated pharmaceutical company, today announced it will be presenting at the Planet MicroCap Toronto 2026 powered by…
HSE failing to collect millions of euro owed by pharma companies
“IT SIMPLY CANNOT be the case the HSE pays its bills… and then at the same time the HSE fails to collect the income from sources which legitimately owe money to the service.” This concern was raised in one of the last memos…
Q2 Results 23rd Oct Live: Infosys, Adani Power, JSW Steel, Tata Motors, Shriram Fin, Torrent Pharma, CG Power, BPCL, Dr Reddys Lab Share to announce Q2 results
Q2 Results Today, 23rd October 2026 Live Updates: Q2 Results Today, 23rd October 2026 Live Updates: Find all the latest Q2 results 2026 updates of Adani Power, Amwill Health Care, Automotive Stampings and Assemblies, Atul, Bank of India, Bharat…
Roche CEO slams Europe for failing to reward innovation
“The US and Asia really play to win, and I feel Europe is more and more playing not to lose,” Thomas Schinecker, CEO of the Swiss drugmaker, said in an interview on Bloomberg Television. Roche will “only invest in countries in…
Legend Biotech Stock: CARVYKTI Makes Billions, But The Profits Are Elusive (NASDAQ:LEGN)
CARVYKTI's quarterly sales reached $710 million, but Legend's high expenses have kept recurring profitability low. Q2 results show improving operating leverage, with collaboration revenue growing faster than associated costs. I rate LEGN a cautious…
Vimian Group AB (publ) (VIMGF) Q3 2026 Earnings Call Transcript
Vimian Group AB (publ) (VIMGF) Q3 2026 Earnings Call October 22, 2026 3:00 AM EDT Alireza Tajbakhsh - Chief Executive Officer Carl Johan Boudrie - Deputy CEO, CFO & Interim Head of Specialty Pharma Adela Dashian - Jefferies LLC, Research Division…
NDTV Profit Reports Three Stock-Futures Calls From ICICI Securities' Jay Thakkar
NDTV Profit reported on Oct. 22 that Jay Thakkar, vice president and head of derivatives and quant research at ICICI Securities, outlined three Indian stock-futures positions for the session: two long positions and one short. The calls included…
Sensex plunges over 400 points
Indian equity markets ended in the red for the third consecutive session on Thursday, with the Sensex plunging over 400 points and the Nifty slipping below the 22,700 mark, as elevated crude oil prices and escalating geopolitical tensions weighed…
How Safe Is Long-Term Upadacitinib in Moderate-to-Severe Atopic Dermatitis?
In 2022, the FDA approved the use of once-daily oral upadacitinib (Rinvoq) for the treatment of moderate-to-severe atopic dermatitis (AD) in adults and adolescents. Since then, this Janus kinase (JAK) inhibitor has remained highly effective, with a…
Zions Bancorporation: Q3 Results Support A Bullish View As Loan Demand Proves Resilient
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
SAT Hospital in Keralam rejects charges of 'clinical trial drugs' given to SMA-afflicted children
SAT Hospital in Thiruvananthapuram, Keralam, the premier tertiary-level child health institution in the State's public sector and one of the chosen Centres of Excellence for Rare Diseases in the country, has found itself in the eye of the storm…
Dr Xand van Tulleken picks his favourite books
The TV doctor and presenter of BBC Radio 4's “What's Up Docs?” picks his favourite books. He is talking about his own latest book, “Make Me Well”, at the Stratford Literary Festival on 30 October. I thought this book by…
Receive a Daily briefing on Pharma Industry News
Get Started